# Single Dose Crossover Comparative Bioavailability Study of Two Formulations of Fluconazole 200 mg in Healthy Adult Subjects Under Fasting Conditions

> **NCT04038008** · PHASE1 · COMPLETED · sponsor: **Pharmtechnology LLC** · enrollment: 26 (actual)

## Conditions studied

- Bioequivalence

## Interventions

- **DRUG:** Fluconazole
- **DRUG:** Diflucan®

## Key facts

- **NCT ID:** NCT04038008
- **Lead sponsor:** Pharmtechnology LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-26
- **Primary completion:** 2019-09-17
- **Final completion:** 2020-01-13
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2023-11-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04038008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04038008, "Single Dose Crossover Comparative Bioavailability Study of Two Formulations of Fluconazole 200 mg in Healthy Adult Subjects Under Fasting Conditions". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04038008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*